Cargando…
Human cytomegalovirus and transplantation: drug development and regulatory issues
Cytomegalovirus (CMV) infection is highly prevalent worldwide and can cause serious disease among immunocompromised individuals, including persons with HIV and transplant recipients on immunosuppressive therapies. It can also result in congenital cytomegalovirus when women are infected during pregna...
Autores principales: | McIntosh, Megan, Hauschild, Benjamin, Miller, Veronica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mediscript Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967965/ https://www.ncbi.nlm.nih.gov/pubmed/27482453 |
Ejemplares similares
-
Human cytomegalovirus infection: A considerable issue following allogeneic hematopoietic stem cell transplantation
por: Zhou, Xinyi, et al.
Publicado: (2021) -
IgA binds to the AD‐2 epitope of glycoprotein B and neutralizes human cytomegalovirus
por: Siddiqui, Saima, et al.
Publicado: (2020) -
Src family kinase activity drives cytomegalovirus reactivation by recruiting MOZ histone acetyltransferase activity to the viral promoter
por: Dupont, Liane, et al.
Publicado: (2019) -
Development of vaccines against the sexually transmitted infections gonorrhoea, syphilis, Chlamydia, herpes simplex virus, human immunodeficiency virus and Zika virus
por: McIntosh, Edwin David G.
Publicado: (2020) -
Cytomegalovirus infection in transplant recipients
por: Azevedo*, Luiz Sergio, et al.
Publicado: (2015)